How the product works:
Brimonidine is a selective alpha-2 adrenergic receptor agonist. When applied to the skin, it constricts dilated superficial blood vessels, leading to a rapid and noticeable reduction in facial redness. The effect appears shortly after application and lasts for several hours.
Who it is recommended for:
Clinical studies and evidence:
Clinical trials have demonstrated that topical brimonidine significantly reduces facial erythema compared with placebo. The product is widely used in dermatology and supported by international clinical guidelines for rosacea management.
The gel is used to temporarily reduce skin redness through vasoconstrictive action.
Apply a thin layer of the gel once daily to the affected areas of the face. Avoid contact with eyes, mucous membranes, and broken skin. The skin should be clean and dry before application. Duration of use should be determined by a healthcare professional.
Contraindications:
Side effects:
